C2-symmetric bis(phosphinite) Ru(II) complexes for reduction of ketones
have synthesized new ruthenium(II) complexes of C2-symmetric
ferrocenyl bis(phosphinite) ligands and used them as catalysts in
ruthenium-catalysed asymmetric transfer hydrogenation of various
ketones.
68.90, 69.11, 69.89 (br, C5H4 + CH2OP), 58.25 (CHN), 46.11 (CH2NH),
36.07 (CH2Ph), 30.09 (CH(CH3)2 of p-cymene), 21.79, 22.02 (CH(CH3)2
of p-cymene), 17.50 (CH3 of p-cymene). 31P-{1H} NMR (162.0 MHz,
CDCl3, δ, ppm): 113.8 (s, O-PPh2). IR (KBr pellet, cmꢀ1): ν(NH): 3332;
ν(CH): 2860, 2925, 3028, 3060; ν(C¼C–Cp): 1447; ν(O–P): 1021. Anal.
Calcd for [C74H82N2O2P2FeRu2Cl4] (1493.3 g molꢀ1) (%): C, 59.52; N,
1.88; H, 5.55. Found (%): C, 59.48, N, 1.80, H, 5.51%. [α]2D0 +66.44 (C
1.2, MeOH).
Experimental
Materials and methods
(S)-Bis[[N-(2-diphenylphosphinite-1-phenyl)ethyl]-1,1′-ferrocenylmethyldiamine
(dichloro η6-p-cymene ruthenium(II))] (2)
Unless otherwise stated, all reactions were performed under argon
in flame-dried glassware using standard Schlenk techniques. All
solvents were purified by distillation over drying agents using
certain procedures prior to use and were transferred under argon.
All reagents were purchased from Fluka and used as received.
Analytical-grade and deuterated solvents were purchased from
Merck.
Yield 195 mg, 92%; m.p. 168–170°C. 1H NMR (400.1 MHz, CDCl3, δ,
ppm): 7.76–7.85 (m, 8H, o-C6H5OP), 7.28, 7.37 (m, 10H, C6H5
+
12H, C6H5OP), 5.15 (br, 8H, C6H4 of p-cymene), 3.86–4.03 (br, 8H,
C5H4 + 2H, CHNH+ 4H, CH2OP), 3.26 (br, 4H, CH2NH), 2.60 (br, 2H,
CH(CH3)2 of p-cymene), 1.83 (br, 6H, CH3 of p-cymene), 1.06 (m,
12H, CH(CH3)2 of p-cymene). 13C NMR (100.6 MHz, CDCl3, δ, ppm):
127.97, 128.06, 128.74, 129.45, 130.96, 131.22 (C6H5 + C6H5OP),
97.10, 111.36 (quaternary carbons of p-cymene), 87.55, 87.70,
90.49, 91.15 (C6H4 of p-cymene), 67.18, 67.83, 68.14, 68.74, 71.03
(C5H4 + CH2OP), 62.33 (CHN), 46.05 (CH2NH), 30.10 (CH(CH3)2 of
p-cymene), 21.74–21.92 (CH(CH3)2 of p-cymene), 17.55 (CH3 of
p-cymene). 31P-{1H} NMR (162.0 MHz, CDCl3, δ, ppm): 109.5 (s,
O-PPh2). IR (KBr pellet, cmꢀ1): ν(NH): 3323; ν(CH): 2865, 2917,
3025, 3064; ν(C¼C–Cp): 1436; ν(O–P): 1018. Anal. Calcd
for [C72H78N2O2P2FeRu2Cl4] (1465.2 g molꢀ1) (%): C, 59.02; N, 1.91;
H, 5.38. Found (%): C, 58.92; N, 1.80; H, 5.22. [α]2D0 +77.8 (C 1.2,
MeOH).
1H NMR (at 400.1 MHz), 13C NMR (at 100.6 MHz) and 31P-{1H} NMR
(at 162.0 MHz) spectra were recorded using a Bruker AV400 spec-
trometer, with tetramethylsilane as an internal standard for 1H
NMR and 13C NMR or 85% H3PO4 as the external reference for
31P-{1H} NMR. Infrared (IR) spectra were recorded with a Mattson
1000 ATI UNICAM FT-IR spectrometer as KBr pellets. Elemental
analysis was carried out using a Fision EA 1108 CHNS-O instrument.
Melting points were recorded with Gallenkamp apparatus with
open capillaries. GC analyses were performed using a Shimadzu
GC 2010 Plus gas chromatograph equipped with a Cyclodex
B (Agilent) capillary column (30 m × 0.32 mm inner diameter ×
0.25 μm film thickness). Racemic samples of alcohols were obtained
by reduction of the corresponding ketones with NaBH4 and used
as authentic samples for ee determination. The GC parameters
for asymmetric transfer hydrogenation of ketones were as follows:
initial temperature, 50°C; initial time, 1.1 min; solvent delay,
4.48 min; temperature ramp, 1.3°C minꢀ1; final temperature,
150°C; initial time, 2.2 min; temperature ramp, 2.15°C minꢀ1; final
temperature, 250°C; initial time, 3.3 min; final time, 44.33 min; injec-
tor port temperature, 200°C; detector temperature, 200°C; injection
volume, 2.0 μl.
(S)-Bis[[N-(2-diphenylphosphinite-1-isobutyl)ethyl]-1,1′-
ferrocenylmethyldiamine (dichloro η6-p-cymene ruthenium(II))] (3)
Yield 198 mg, 88%; m.p. 126–128°C. 1H NMR (400.1 MHz, CDCl3, δ,
ppm): 7.80–7.49 (m, 8H, o-C6H5OP), 7.40–7.42 (b, 12H, m- and p-
C6H5OP), 5.20–5.29 (m, 8H, C6H4 of p-cymene), 4.25 (s, 4H, C5H4),
4.08 (s, H C5H4), 3.61–3.70 (b, 4H, CH2NH + 2H, CH2OP (a)), 3.91 (b,
2H, CH2OP (b)), 2.79 (b, 2H, NHCH), 2.59–2.63 (m, 2H, CH(CH3)2 of
p-cymene), 1.88 (s, 6H, CH3 of p-cymene), 1.33–1.35 (b, 4H, CHCH2
+ 2H, CH(CH3)2), 1.03–1.09 (m, 12H, CH(CH3)2 of p-cymene), 0.72–
0.77 (m, 12H, CH(CH3)2). 13C NMR (100.6 MHz, CDCl3, δ, ppm):
127.95, 128.04, 132.11, (C6H5OP), 97.24, 111.30 (quaternary carbons
of p-cymene), 87.42, 87.87, 90.32, 91.22 (p-cymene C6H4), 67.68,
68.13, 68.85, 69.03, 69.79 (C5H4 + CH2OP), 55.01 (CHN), 45.81
(CH2NH), 40.46 (CHCH2), 30.11 (CH of p-cymene), 24.63 (CHCH3),
21.69, 21.98, 22.36, 23.03 (CH(CH3)2 + CH(CH3)2 of p-cymene),
17.58 (CH3 of p-cymene). 31P-{1H} NMR (162.0 MHz, CDCl3, δ,
ppm): 109.5 (s, O-PPh2). IR (KBr pellet, cmꢀ1): ν(NH): 3330; ν(CH):
2867, 2955, 2961, 3070; ν(C¼C–Cp): 1436; ν(O–P): 1021. Anal. Calcd
for [C68H86N2O2P2FeRu2Cl4] (1425.2 g molꢀ1) (%): C, 57.30; N, 1.97;
H, 6.08. Found (%): C, 57.23; N, 1.94; H, 6.01. [α]2D0 +47.3 (C 1.2,
MeOH).
General procedure for synthesis of ferrocene-based bis
(phosphinite) ruthenium(II) complexes (1–8)
To a solution of ferrocene-based phosphinite ligand[35] (1 equiv.) in
dry toluene (20 ml), the metal precursor [Ru(η6-p-cymene)(μ-Cl)Cl]2
(1 equiv.) was added at room temperature. The mixture was stirred
until the resonance of free ligand disappeared in the 31P NMR spec-
trum (1 to 14 h). The solvent was evaporated to ca 1–2 ml and
petroleum ether (20 ml) was added to yield a tile-red powder which
was washed with diethylether–n-hexane (1:1) and then dried in
vacuum.
(S)-Bis[[N-(2-diphenylphosphinite-1-benzyl)ethyl]-1,1′-ferrocenylmethyldiamine
(dichloro η6-p-cymene ruthenium(II))] (1)
(S)-Bis[[N-(2-diphenylphosphinite-1-sec-butyl)ethyl]-1,1′-
Yield 180 mg, 88%; m.p. 136–138°C. 1H NMR (400.1 MHz, CDCl3, δ,
ppm): 7.82–7.88 (m, 8H, o-C6H5P), 7.05–7.44 (m, 10H, C6H5 +12H,
m- and p-C6H5P), 5.13–5.22 (m, 8H, C6H4 of p-cymene), 3.68–4.17
(m, 8H, C5H4 + 4H, (CH2OP) + 4H, CH2NH), 3.06 (br, 2H, CHNH),
2.84–2.93 (m, 4H, CH2Ph), 2.60–2.53 (m, 2H, CH(CH3)2 of p-cymene),
1.80 (s, 6H, CH3 of p-cymene), 1.06 (d, 6H, J = 6.9 Hz, CH(CH3)2 of p-
ferrocenylmethyldiamine (dichloro η6-p-cymene ruthenium(II))] (4)
Yield 180 mg, 80%; m.p. 129–131°C. 1H NMR (400.1 MHz, CDCl3, δ,
ppm): 7.84–7.95 (m, 8H, o-C6H5P), 7.42 (b, 12H, m- and p-C6H5P),
5.21–5.33 (m, 8H, C6H4 of p-cymene), 4.07–4.16 (br, 8H, C5H4), 3.91
(br, 2H, CH2OP (a)), 3.69 (br, 2H, CH2OP (b)), 3.48 (br, 4H, CH2NH),
2.61–2.65 (b, 2H, CHNH + 2H, CH of p-cymene), 1.60 (b, 2H, CH3CH),
1.28–1.33 (m, 4H, CH2CH3), 1.88 (s, 6H, CH3 of p-cymene), 1.10 (d, 6H,
J = 7.0 Hz, CH(CH3)2 of p-cymene), 1.06 (d, 6H, J = 6.7 Hz, CH(CH3)2 of
p-cymene), 0.80–0.92 (m, 6H, CHCH3 + 6H, CH2CH3). 13C NMR (100.6
cymene (a)), 1.01 (d, 6H, J = 6.6 Hz, CH(CH3)2 of p-cymene (b)). 13
C
NMR (100.6 MHz, CDCl3, δ, ppm): 127.97, 128.07, 129.03, 131.00,
131.43, 132.39 (C6H5 + C6H5OP), 97.34, 111.41 (quaternary carbons
of p-cymene), 87.33, 87.89, 89.97, 91.14 (C6H4 of p-cymene), 68.71,
Appl. Organometal. Chem. 2015, 29, 764–770
Copyright © 2015 John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/aoc